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Abstract
Severe injuries in the craniofacial complex, resulting from trauma or pathology, present several 
challenges to functional and aesthetic reconstruction. The anatomy and position of the craniofacial 
region make it vulnerable to injury and subsequent local infection due to external bacteria as well 
as those from neighboring structures like the sinuses, nasal passages, and mouth. Porous 
polymethylmethacrylate (PMMA) “space maintainers” have proven useful in staged craniofacial 
reconstruction by promoting healing of overlying soft tissue prior to reconstruction of craniofacial 
bones. We describe herein a method by which the porosity of a prefabricated porous PMMA space 
maintainer, generated by porogen leaching, can be loaded with a thermogelling copolymer-based 
drug delivery system. Porogen leaching, space maintainer prewetting, and thermogel loading all 
significantly affected the loading of a model antibiotic, colistin. Weeks-long release of antibiotic at 
clinically relevant levels was achieved with several formulations. In vitro assays confirmed that the 
released colistin maintained its antibiotic activity against several bacterial targets. Our results 
suggest that this method is a valuable tool in the development of novel therapeutic approaches for 
the treatment of severe complex, infected craniofacial injuries.
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Introduction
The craniofacial region is particularly vulnerable to injury and subsequent wound infection 
due to its anatomy and position. Substantial bone and soft tissue loss can result from severe 
trauma or tumor resection. Reconstruction of these defects often requires a multidisciplinary 
approach with a series of staged procedures.1-3 Emerging craniofacial tissue engineering 
strategies that combine biomaterials, autologous cells, and/or signaling factors offer a 
promising alternative to the prosthetics and other surgical reconstructive approaches 
currently in use.4-5 However, wound bed infection due to contamination at the time of initial 
trauma, repeated surgical interventions, and/or bacterial overgrowth in devascularized and 
devitalized damaged tissues, remains a major barrier to effective reconstruction and 
implementation of tissue engineering approaches. Infection is of particular concern in 
craniofacial reconstruction, where tissue defects are often exposed to bacteria not only from 
the external environment, but also from neighboring structures including the sinuses, nasal 
passages, and the mouth.6-7 For instance, wound infection rates approaching 100% have 
been reported following gunshot injuries to the face.8-9
Several groups, including ours, have previously reported on the optimization of 
polymethylmethacrylate (PMMA) temporary implants, or “space maintainers,” for complex 
craniofacial reconstruction.10-19 Space maintainers ideally serve a dual purpose, enabling 
healing of the soft tissue envelope overlying the bony injury, while preventing wound 
contracture in order to preserve the hard tissue defect site. Soft tissue healing and 
maintenance of defect geometry facilitate later reconstruction and may allow time for the 
expansion of autologous cells to enable generation of a custom-designed tissue engineered 
construct.10,19 When compared to solid polymeric space maintainers, porous implants have 
shown superior outcomes in terms of healing of the overlying soft tissue cuff.9,10,18 
However, the use of porous implants presents a challenge because the pores can harbor 
bacteria, resulting in a higher available surface area for biofilm formation and subsequent 
wound infection.15,20,21
In recent years, the search for improved craniofacial reconstructive strategies to manage 
local infection and promote tissue regeneration has been further motivated by combat 
operations, where the prevalent use of improvised explosive devices has resulted in a high 
frequency of severe craniofacial injuries.22-25 Unfortunately, many soldiers have returned 
with combat wound infections and even osteomyelitis, often with multi-drug resistant 
Acinetobacter baumannii species.26-27 One of the last-resort antibiotics for these infections, 
colistin, is limited by its poor penetration into bone, requiring prolonged therapy that carries 
a significant risk of kidney and nerve damage due to colistin’s known nephro- and 
neurotoxic side effects.12,28 Placement of a porous space maintainer into such a 
contaminated wound would further complicate therapy by providing an additional barrier to 
diffusion.
To address this challenge, several strategies for the fabrication of antibiotic-loaded porous 
space maintainers have been described to enable local delivery of various antibiotics, 
including colistin.12,13,15,29 Our group has described several techniques for incorporating 
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drug delivery systems into porous PMMA space maintainers to enable precise spatial and 
temporal control of antibiotic release.12,13,15 However, translation of these designs into 
clinical products remains quite challenging due to their numerous components and overall 
complexity. With that in mind, the goal of this study was to develop an antibiotic delivery 
system based on porous space maintainers that can be assembled at the point of care (e.g., 
within the operating room) and deliver antibiotics at meaningful concentrations, i.e., 
exceeding the minimum inhibitory concentration (MIC) for common pathogens, for a period 
of a week or more, as would be required in the treatment of infected craniofacial bone 
defects while awaiting soft tissue healing.
Previous design of antibiotic-releasing space maintainers utilized antibiotic-loaded 
biodegradable microspheres incorporated directly into the solid phase of the porous space 
maintainer during fabrication.12,13,15 The current design, intended for point of care loading 
of antibiotics, is based on previously described non-drug-loaded porous PMMA-based space 
maintainers, in which 30 wt% of a 9% carboxymethylcellulose (CMC) hydrogel was used as 
a porogen within the bulk material.10 This formulation was shown to optimize in vivo 
closure of intraoral soft tissue defects while inducing a favorable tissue response with 
minimal inflammatory reaction at the implant-tissue interface.10
The goal of this study is to develop a simple and convenient method to load prefabricated 
porous space maintainers with a variety of antibiotics. A thermogelling copolymer was 
selected as the antibiotic carrier with the intention that it could penetrate the pores of the 
space maintainer in its liquid state and subsequently undergo a transition at body 
temperature to form a gel that serves as a depot for drug delivery. The thermogelling 
copolymer formulations selected consists of poly(DL-lactic-co-glycolic acid) (PLGA) and 
poly(ethylene glycol) (PEG), since this type of PLGA-PEG-PLGA block copolymer is also 
currently being studied for controlled release of chemotherapeutics.30,31
Although drug release from both unmodified thermogels32-34 as well as from solid PMMA35 
typically occurs on the scale of hours to days, clinically relevant weeks-long release from 
thermogel-loaded porous PMMA space maintainers could be achieved by optimizing 
parameters such as the lactic acid to glycolic acid ratio (L:G) of the PLGA block, thermogel 
loading method, and prewetting of the PMMA space maintainer. Colistin was selected as a 
model antibiotic due to its relevance in the treatment of severe complex, infected 
craniofacial injuries. The objective of this work was to develop a method for incorporating 
an antibiotic drug delivery system into prefabricated porous space maintainers to provide 
antibiotic release over the course of several weeks, as might be necessary to treat infected 
craniofacial bone defects while awaiting soft tissue envelope healing; we additionally aimed 
to deliver the antibiotic at meaningful concentrations, which we defined as a concentration 
exceeding the minimum inhibitory concentration of bacteria commonly infecting these 
wounds, including Acinetobacter baumannii. We hypothesize that in vitro colistin release 
can be modulated by varying scaffold prewetting, porogen leaching, thermogel L:G ratio, as 
well as the thermogel loading method, without disrupting colistin’s in vitro anti-bacterial 
activity.
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Materials and Methods
Experimental Design
The study groups are summarized in Table 1. All 12 groups consisted of porous PMMA 
space maintainers fabricated according to established methods9 using a 9% w/w 
carboxymethylcellulose (CMC) hydrogel as a porogen, which was mixed at 30 w/w% with 
the contents of a clinical-grade kit for methylmethacrylate (MMA) polymerization, as 
detailed below. After fabrication and curing, CMC was leached from the space maintainer 
pores, and various methods were subsequently used to fill the pores with colistin. All 
methods utilized 5% w/v aqueous solutions of colistin, some of which also contained 
thermogelling polymers dissolved at 25% w/v. A factorial design was used to evaluate the 
effect of 2 porous space maintainer treatments (“prewet” vs. “no prewet”), thermogelling 
polymer type (“L:G 1:1”, “L:G 3:1”, and “No gel”), and thermogel loading method 
(“pregel” vs. “dip”). Two additional control groups were included consisting of “prewet” and 
“no prewet” scaffolds which did not undergo leaching of CMC prior to antibiotic loading 
(“No gel, +CMC”). A schematic of the “pregel” and “dip” loading methods is depicted in 
Figure 1.
Preparation of Porous PMMA Space Maintainers
Porous PMMA space maintainers were fabricated according to established methods10 using 
clinical-grade and United States Pharmocopeia (USP)-grade materials. A CMC hydrogel 
was prepared by dissolving 9% w/w low viscosity CMC (Type 7LFPH, Ashland Inc., 
Covington, KY) in ultrapure (Type I) water (Millipore Super-Q, Billerica, MA). A single 
hydrogel batch was used for all experiments described herein. This hydrogel served as a 
porogen to generate porous PMMA constructs using a clinical-grade bone cement kit 
(SmartSet High Viscosity, Depuy Orthopaedics, Warsaw IN), containing a powder phase of 
MMA/methyl acrylate copolymer, benzoyl peroxide, and zirconium dioxide, and a liquid 
phase consisting of MMA, N-N-dimethyl-p-toluidine, and hydroquinone. To fabricate 
porous space maintainers containing 30% w/w CMC hydrogel in PMMA, CMC hydrogel 
was thoroughly blended with the powder phase, the liquid phase was added, and thoroughly 
mixed for 90 sec to achieve a dough-like consistency. This mixture was packed into custom-
fabricated cylindrical Teflon® (Dupont, Wilmington, DE) molds, 10 mm diameter by 6 mm 
height, and allowed to harden at room temperature for 30 min.
The resulting specimens were randomly assigned to each of the study groups. For all 
constructs except those in +CMC groups, each space maintainer was placed in a 200-fold 
volumetric excess of ultrapure water and gently agitated to leach out the CMC. Ultrapure 
water was aspirated and replaced at 12h intervals. After 48h, all constructs were vacuum-
dried for 24h. The dry weight of each space maintainer was determined immediately 
following fabrication as well as after vacuum drying to determine the wt% of CMC and/or 
water removed. One day prior to beginning antibiotic release, specimens assigned to 
“prewet” groups were placed in a 200-fold volumetric excess of 50% v/v ethanol in 
ultrapure water, and incubated for 12h at room temperature with gentle agitation, followed 
by 2h in sterile phosphate-buffered saline (PBS, pH 7.4).
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Thermogelling Polymer Preparation
Triblock copolymers of PLGA-PEG-PLGA capable of thermogelling and suitable for in vivo 
use were obtained in two different formulations (AK12 and AK24, Akina Polymers, West 
Lafayette, IN), which differed in terms of the lactic- to glycolic-acid (L:G) ratios of the 
PLGA blocks. According to data provided by the manufacturer, the L:G ratios of the specific 
copolymer lots used herein were 16:21 and 19:7, respectively, and are approximated as 1:1 
and 3:1 throughout the text. These thermogelling polymers were dissolved at 25% w/v in 
sterile PBS (pH 7.4) with vigorous agitation at 4°C for 72h according to the manufacturer’s 
instructions and used immediately for antibiotic-loading of space maintainers.
Antibiotic Loading and Release
Colistin sulfate salt (C4461, Sigma-Aldrich, St. Louis, MO) was dissolved at 5% w/v in 
sterile PBS, as well as at 5% w/v in each of the two thermogelling polymer solutions. Space 
maintainers assigned to thermogel-free groups were each submerged in colistin/PBS solution 
at room temperature with gentle agitation for 10 min. Space maintainers assigned to 
thermogel groups were submerged in the appropriate colistin/thermogel solution with 
vigorous agitation at 4°C. After 10 min, those assigned to “pregel” groups were transferred 
to a 37°C incubator for 10 min (remaining in the thermogel/colistin solution), while those in 
“dip” groups were immediately removed from the solution. Following incubation in the 
respective antibiotic solutions, the weight of each space maintainer was obtained, and then 5 
ml of prewarmed, sterile PBS were then added to each space maintainer. Samples were 
incubated at 37°C with mild agitation. At predetermined time points (12h and days 1, 2, 3, 4, 
5, 7, 10, 14, 21, 28), the entire supernatant was removed and replaced with fresh sterile PBS.
Colistin concentration in the release media was determined via high-performance liquid 
chromatography (HPLC), according to established methods.12,13 Samples were passed 
through 0.2 μm filters and then analyzed using a previously described HPLC system 
consisting of an XTerra® RP 18 column (250 cm × 4.6 μm, Waters, Milford, MA) at 45°C 
mounted within a Waters 2695 separation module and attached to a 2996 photodiode array 
detector (Waters). The mobile phase had a flow rate of 0.5 ml/min and consisted of HPLC-
grade acetonitrile with 0.1% v/v trifluoroacetic acid (Sigma) and ultrapure water with 0.1% 
v/v trifluoroacetic acid, with a linear gradient of 10-65% v/v acetonitrile in water over 20 
min. Absorbance was monitored at 214 nm. Standard solutions of colistin ranging from 
5-1000 μg/ml in sterile PBS (pH 7.4) were used to generate calibration curves correlating 
colistin concentration to the combined peak areas of colistin A and colistin B, which were 
eluted at 13.2 min and 13.9 min, respectively. Daily release was approximated by dividing 
the absolute amount of colistin in the release media at a particular timepoint by the number 
of 24h periods that had elapsed since the previous time point. Cumulative release represents 
a percentage of the total amount of colistin released over time.
Bacterial Susceptibility
The antibiotic activity of colistin in the release media was analyzed using Acinetobacter 
baumannii, as previously described15, as well as a second bacterial species, Escherichia coli 
(ATCC 25922, American Type Culture Collection, Manassas, VA), according to 
International Standard ISO 20776-1. A. baumannii (isolate #170) was provided by Brooke 
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Army Medical Center (San Antonio, TX) and originated from a culture specimen of a deep 
wound of a soldier injured in Operation Iraqi Freedom. The 12h time point was selected as 
colistin concentrations were sufficiently high for all groups to generate the entire range of 
required working solutions outlined in ISO 20776-1. For each sample, an aliquot of the 
release media was sterile-filtered and serially diluted using sterile ultrapure water followed 
by additional dilution with Mueller Hinton broth (Sigma) to generate 50 μl aliquots with 
concentrations ranging from 0-32 μg/ml. Two identical sets of sterile microwell plates were 
prepared, one for each bacterial strain. Each plate contained experimental samples as well as 
standard dilutions of fresh colistin. For one set of plates, a standard 0.5 McFarland 
suspension of A. baumannii cultured in Mueller Hinton broth was diluted 1:100 with broth 
and 50 μl were added to each well. The same procedure was repeated for the second set of 
plates using E. coli. Experiments were performed in triplicate. The lowest concentration well 
without growth after 18h at 37°C was denoted the minimum inhibitory concentration (MIC).
Statistics
All values are expressed as mean ± standard deviation for n = 4 specimens per group, except 
for the values in Table 2 which represent mean ± standard deviation for n = 10 per group and 
the data points in Figure 5, each of which represents the mean ± standard deviation for n=8 
specimens per variable. Space maintainer weights, burst release values, and bacterial 
susceptibility results were each analyzed using analysis of variance (p < 0.05), followed by 
Bonferroni post hoc analysis (p < 0.05) for multiple comparisons. Theoretical and actual 
colistin loading values for the various space maintainer groups were compared using two-
way analysis of variance (p < 0.05), followed by Bonferroni post hoc analysis (p < 0.05) for 
multiple comparisons. Release data were analyzed using a repeated measures analysis of 
variance (p < 0.05) followed by Bonferroni post hoc analysis (p < 0.05). The effect of two 
independent factors (prewetting and CMC leaching, or prewetting and thermogel loading 
method) on total colistin loading was evaluated using two-way analysis of variance (p < 
0.05).
Results
PMMA Space Maintainer Characteristics
PMMA space maintainers for this study were prepared in five batches and then randomly 
assigned to the groups depicted in Table 1. When space maintainers from each batch were 
compared, there were no differences in average weight (p > 0.05) either before or after CMC 
leaching, as shown in Table 2. Similarly, there were no differences amongst the twelve 
experimental groups in average space maintainer weight (p > 0.05) either before or after 
CMC leaching (Table 3). Within each group, initial and dry weights differed significantly (p 
< 0.05).
Antibiotic Loading
On Day 0 of the release study, the applicable space maintainer groups were prewet and then 
all groups were loaded with colistin according to the experimental design (Table 1, Figure 
1). Following loading, the average weight for each group increased significantly (p < 0.05) 
compared to the dry weight shown in Table 3, except for “No gel, +CMC (+prewet),” which 
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still showed an increasing trend (p > 0.05) from a dry weight of 75 ± 5% to 81 ± 2% initial 
space maintainer weight on Day 0. Figure 2 summarizes the weights for all groups on Day 0 
of the release study as a percentage of the initial weight of each space maintainer. For all 
pairs of treatment groups except “No gel, +CMC,” the +prewet version weighed 
significantly more than the non-prewet group (p < 0.05). “No gel, +CMC” (+prewet and no 
prewet) had the lowest weight on Day 0, while “L:G 3:1, pregel” had the highest, with the 
+prewet group significantly differing from all others (p < 0.05).
In addition to the weight increase due to prewetting, for each thermogel type, “pregel” 
groups weighed more than corresponding (+prewet or no prewet) “dip” groups (p < 0.05). 
However, this did not correlate with increased total colistin loading, as shown in Figure 3. 
The total amount of colistin released from each space maintainer, measured over time via 
HPLC until the release reached a consistent value (“Actual colistin”) is compared to 
“Theoretical colistin” values derived from the weight gain of each dried space maintainer 
(Day 0 – dry), taking into account the weight percent of colistin in each loading solution as 
well as the weight of the thermogel, if applicable. For all +prewet groups except “No gel, 
+CMC (+prewet)” and “L:G 1:1, dip (+prewet),” the theoretical colistin value significantly 
(p > 0.05) overestimated the actual measured value. In contrast, for all non-prewet groups, 
except “L:G 3:1, dip (no prewet),” the theoretical total colistin loading was an adequate 
estimate of the true value as it did not differ significantly (p > 0.05) from the actual value.
Antibiotic Release
Colistin release profiles from all 12 groups are shown in Figure 4. All groups exhibited a 
notable 24h burst release followed by daily release of non-zero amounts of colistin (note per 
day normalization in y-axis). Burst release values measured at 12h ranged from 4200 ± 750 
to 22800 ± 1800 μg colistin per ml construct volume, for “No gel, +CMC (+prewet)” and 
“L:G 1:1, dip (no prewet),” respectively. When taken as a percentage of the total colistin 
released from each construct, 12h burst release ranged from 69 ± 11% to 90 ± 3%, with non-
prewet groups generally having significantly lower (p < 0.05) burst release values than their 
corresponding +prewet counterparts, as demonstrated in Table 4. Following this initial burst 
release, non-zero colistin release was noted for all groups, with the daily amount released 
generally declining with time (Figure 4). Several of the non-prewet groups showed a small 
spike in daily release around days 14-21, with subsequent decline in release, which remained 
at non-zero levels by day 28. In contrast, for all prewet groups except “L:G 3:1, pregel 
(+prewet),” colistin release had ceased by day 28. Almost all groups had significantly 
different (p < 0.05) release profiles, except for the two non-prewet pregel groups, whose 
release did not differ significantly, but differed from all other groups. In addition, “LG 1:1, 
pregel (+prewet)” did not significantly differ from either “No gel (+prewet)” or “LG 3:1, dip 
(+prewet),” though the latter two release profiles significantly differed from each other (p < 
0.05). At day 28, none of the prewet groups had a daily release of colistin greater than the 
MIC of A. baumannii (8 μg/ml, Table 5); in the non-prewet groups, all groups with the 
exception of No gel, +CMC, and LG 1:1 pregel had daily release in excess of the MIC of A. 
baumannii.
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Main effects analysis (Figure 5) of the study groups indicated that leaching of CMC, 
prewetting, and thermogel loading method all significantly affected colistin loading (p < 
0.05). Leaching of CMC, which was done for all space maintainers except those in the two 
“No gel, +CMC” groups, nearly doubled the total amount of colistin loaded (p < 0.05). 
Prewetting significantly reduced colistin loading (p < 0.05) in both the control and 
thermogel-loaded constructs. Pregelling of the two thermogel formulations had opposite 
effects, significantly decreasing colistin loading of “L:G 1:1” constructs, while significantly 
increasing colistin loading of “L:G 3:1” constructs (p < 0.05).
Bacterial Susceptibility
Colistin released from the various space maintainer formulations had a consistent effect on 
A. baumannii, as shown in Table 5. Fresh colistin, used as a standard, had a MIC of 8 ± 0 
μg/ml. All other groups also had a MIC of 8 ± 0 μg/ml for A. baumannii, except for “L:G 
3:1 dip (no prewet),” which had a significantly lower MIC of 4 ± 2 μg/ml (p < 0.05). E. coli 
showed a more variable susceptibility to colistin from the various samples (Table 5). Fresh 
colistin standard resulted in a MIC of 4 ± 0 μg/ml. Most of the study formulations resulted in 
slightly higher MIC values for E. coli, which significantly differed from the standard in the 
case of six groups: “No gel, +CMC” (both +prewet and no prewet); “No gel” (+prewet); 
“L:G 1:1” (no prewet, both pregel and dip groups);l and “L:G 3:1, dip” (no prewet), all of 
which had a MIC of 8 ± 0 μg/ml.
Discussion
PMMA space maintainers are frequently used to stent soft tissue in infected wounds, 
allowing time for the soft tissue to heal, while preserving a “pocket” for future bone 
reconstruction.35 The advent of advanced reconstructive techniques, including vascularized 
free tissue transfer, has decreased the frequency of space maintainer use in civilian 
craniofacial reconstruction.1,2,5,7,8,10 However, recent conflicts around the world have 
resulted in a growing number of patients with devastating blast injuries complicated by 
heavy microbial contamination, often with multi-drug resistant Acinetobacter 
baumannii.22-27 It is often impossible to follow the ideal civilian surgical reconstruction 
timeline in these patients, in which vascularized free tissue transfer would occur within 3-7 
days, due to challenges including delayed evacuation and limited resources at nearby 
hospitals.1,25 The method described herein, in which antibiotic-laden PMMA space 
maintainers can be readily assembled with a variety of antibiotics and provide weeks-long 
release, presents an important advance in the care of these wounded soldiers. This method 
can also be extrapolated to the care of civilian patients, for instance, in those with infected 
total hip replacements, where it is commonplace to perform staged reconstruction that 
includes antibiotic-loaded PMMA space maintainers.35-36
Porous space maintainers were selected in anticipation of future surgical implantation, as 
they have shown superior outcomes compared to non-porous PMMA implants in terms of 
clinical and in vivo healing of the overlying soft tissue cuff.10,11,19 All groups consisted of 
porous PMMA space maintainers fabricated according to established methods using a 9% 
w/w CMC hydrogel as a porogen, mixed at 30 w/w% with a clinical-grade kit for MMA 
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polymerization, which has been previously shown to result in spacers with 16.9 ± 4.1% 
porosity and 39.7 ± 9.4% interconnectivity (at a 40 μm minimum connection size) as 
measured by microcomputed tomography (μ-CT).10 However, porosity presents a challenge 
as it creates a higher surface area for bacterial contamination.15,20,21 Our method takes 
advantage of the proven benefits of prefabricated porous PMMA space maintainers, and 
diminishes the risk of later infection by filling the pores with a controlled release system for 
antibiotic delivery. This presents a significant advantage over the current standard of 
antibiotic-loaded solid PMMA space maintainers, in which antibiotic is encapsulated within 
the PMMA phase during polymerization.35 Although technically simple, numerous studies 
have shown that only the antibiotic near the space maintainer surface is released, within 
hours to days, while >90% remains permanently entrapped within the solid PMMA cement 
and unavailable for antimicrobial treatment.35-37 Several recent studies have described 
porous PMMA space maintainers in which antibiotic-loaded degradable PLGA or gelatin 
microparticles are incorporated into porous PMMA; the microparticles degrade over time, 
generating further pores within the space maintainer and resulting in weeks-long clinically 
relevant antibiotic release.12,13,15 In these previous studies, the antibiotics or the antibiotic-
loaded microparticles were loaded at the time of space maintainer fabrication. However, the 
flexibility of the porous space maintainer could be further expanded by the development of a 
system based on an infiltrating thermogelling polymer such as PLGA-PEG-PLGA into a 
prefabricated construct.
In this study, colistin was used as a model antibiotic, and the effects of several independent 
factors, including scaffold prewetting, porogen leaching, and thermogel loading method, 
were examined. Prewetting was investigated as a possible means to increase the infiltration 
of thermogelling liquid into the pores of the space maintainer by increasing the 
hydrophilicity of the bulk material, while simultaneously removing leachable methacrylate 
from the construct, improving the biocompatibility of the space maintainer.18 While a 
moderate theoretical loading increase was projected in prewet samples, the prewetting 
appears to negatively impact loading of antibiotic. This indicates that potential affinity 
disparities between the thermogel, water, antibiotic, and bulk materials could have resulted 
in infiltration of more water without thermogel-bound antibiotic or increased diffusion of 
antibiotic from the construct during gelation. The molar ratio of lactic acid to glycolic acid 
also affects the retention of antibiotics38, and it appears that colistin may be retained by 
affinity to the increased hydrophobicity of the L:G 3:1 composition, which contains a higher 
proportion of hydrophobic lactic acid units.
Pre-leaching CMC from constructs significantly increased antibiotic loading, as shown in 
Figure 5, likely by providing more physical space for the thermogel to occupy within the 
pores of the space maintainer. Figure 4 demonstrates that leaching also significantly affected 
the release profile, particularly for the non-prewet spacers (“No gel” vs. “No gel, +CMC”). 
Although significant, the +prewet groups showed less obvious of a difference in release 
profile, which may stem from leaching of some of the CMC from the “No gel, +CMC 
(+prewet)” spacers during the prewet process (Figure 4).
Pre-leaching CMC from constructs improves antibiotic loading by providing more physical 
space for the thermogel to occupy within the pores of the space maintainer.
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The release kinetics suggest an initial diffusion-controlled release of colistin, followed by 
thermogel degradation-controlled release after 14 days up to 28 days, consistent with 
previous studies of drug release from PLGA-PEG-PLGA.38 Shi et al. fabricated porous 
space maintainers using colistin-swollen gelatin microparticles as a porogen and found that 
the drug released with Fickian diffusion kinetics over 10-14 days.13 Similarly, in a study by 
Spicer et al. of colistin-loaded porous space maintainers fabricated using gelatin as a 
porogen, colistin incorporated directly into the gelatin released over 7 days with diffusion-
controlled release kinetics.15 In the same study, colistin-loaded PLGA microparticles were 
shown to release drug from porous space maintainers for up to 8 weeks with initial 
diffusion-controlled release followed by microparticle degradation-controlled release, 
similar to the kinetics seen with PLGA-PEG-PLGA thermogel but on a longer timescale.15 
Colistin is a large, positively charged peptide antibiotic, and as such, physicochemical 
interactions with the PLGA matrix leads to an early burst release followed by degradation-
controlled release.39 The 28 day release observed with PLGA-PEG-PLGA compared to the 
8 week release observed with PLGA microparticles may be a result of the incorporation of 
hydrophilic PEG, reducing the affinity between drug and material.15,38 While the addition of 
PEG decreases the duration of release, the use of a triblock copolymer allows for 
thermogelation within the pores of a prefabricated porous space maintainers, resulting in 
greater flexibility to choose a variety of drugs at the time of implantation. PLGA-PEG-
PLGA has also been evaluated with other drugs, and it has been demonstrated that the 
release kinetics are affected by the type of drug being released. Qiao et al. demonstrated that 
when 5-fluorouracil, a hydrophilic drug, is loaded into a PLGA-PEG-PLGA thermogel, 
release appears to be entirely diffusion-mediated; in contrast, incorporation of the 
hydrophobic drug indomethacin results in biphasic release characterized by early diffusion 
and late degradation-controlled release, similar to kinetics seen with colistin in both pure 
PLGA and in the triblock copolymer.38,39 Kim et al. loaded the protein drug insulin into 
PLGA-PEG-PLGA both with and without zinc and showed that in vitro release kinetics are 
likely influenced by the hydrophobicity of insulin, which causes it to partition preferentially 
toward the hydrophobic domains of the polymer micelles.40 A follow-up study by Choi et al. 
also using insulin shows a release profile that is similar to that of indomethacin and colistin, 
highlighting that drug hydrophobicity and partitioning are important parameters that govern 
release kinetics from PLGA-PEG-PLGA copolymers.41
Further studies should include the utilization of alternative antibiotics of varying partition 
coefficient, charge, and/or molecular weight, which could offer insight into the effects of 
antibiotic characteristics on interactions with the thermogel and scaffold. The in vivo 
efficacy of these systems will also be studied. This work could also be expanded to 
investigate the thermogel as a carrier for drug-loaded microparticles or nanoparticles, which 
may impart distinct release kinetics desirable for long-term infection prevention.
Conclusions
This study investigated PLGA-PEG-PLGA thermogelling copolymer as an antibiotic carrier 
for the eventual application of preventing and treating infections that may occur in bone 
defects containing prefabricated implantable porous space maintainers. The effects of 
porogen leaching, space maintainer prewetting, and loading method on drug loading and 
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release kinetics were assessed using colistin as a model drug. In order to improve the loading 
of drug into the space maintainer, space maintainers should be pre-leached of CMC before 
attempting to load the thermogel. Pregelling the thermogel before implantation can result in 
decreased drug delivery, though it appears that increasing the L:G ratio can improve colistin 
loading, which may be due to hydrophobic interactions. Prewetting should be avoided, as 
this decreases the loading of drug. The release kinetics are characterized by diffusion early, 
and after day 14, thermogel degradation appears to mediate release until day 28. The results 
from this study indicate that infiltration of a thermogelling PLGA-PEG-PLGA copolymer 
into the porosity of a prefabricated space maintainer is a simple and effective way to achieve 
controlled release of antibiotics from implantable space maintainers while capitalizing on 
the flexibility to choose a variety or combination of antibiotics at the time of implantation.
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Refer to Web version on PubMed Central for supplementary material.
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PEG poly(ethylene glycol)
PMMA polymethylmethacrylate
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Figure 1. 
A schematic depiction of the “pregel” and “dip” methods used to load prefabricated PMMA 
space maintainers with the various thermogel formulations described in Table 1.
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Figure 2. 
Day 0 space maintainer weight after colistin loading and immediately prior to placement in 
release medium, expressed as percentage of initial space maintainer weight shown in Table 
3. The 12 groups are identified along the bottom of the image using the same notations 
depicted in the study design (Table 1). Groups marked with the same letter (A-D) did not 
significantly differ from each other (p > 0.05), but differ from all other groups (p < 0.05). 
The “L:G 3:1, pregel (+prewet)” group is marked with a “*” to indicate that it significantly 
differs from all other groups (p < 0.05). Each column represents the mean ± standard 
deviation for n=4 space maintainers per group. Each space maintainer’s weight was 
expressed as a percentage of its corresponding initial weight prior to calculation of the mean.
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Figure 3. 
Total colistin loaded into each space maintainer on Day 0. “Actual colistin” values represent 
the total amount released from each space maintainer, measured until the release reached a 
consistent zero value. “Theoretical colistin” values were derived from the weight gain of 
each dried space maintainer upon colistin loading, taking into account the weight percent of 
colistin in each loading solution as well as the presence of thermogel, if applicable. The 12 
groups are identified along the bottom of the image using the same notations depicted in the 
study design (Table 1). Theoretical values with “+” differed significantly from the 
corresponding actual value (p < 0.05). Actual values with “#” significantly differed from all 
other groups (p < 0.05) except those marked with the same notation. Each column represents 
the mean ± standard deviation for n=4 space maintainers per group.
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Figure 4. 
Colistin release profiles from all 12 groups, measured via HPLC at set timepoints. All 
groups had a burst release followed by daily non-zero colistin release. Note the per day 
normalization of the y-axis. Nearly all groups showed significantly different release profiles 
(p < 0.05), except those marked with letters A-C; groups marked with the same letter did not 
differ from each other, but differed from all other groups (p < 0.05). Each data point 
represents the mean ± standard deviation for n=4 space maintainers per group at that 
timepoint. All points have error bars, though they are not long enough to be visualized in 
some cases.
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Figure 5. 
Main effects analysis of the effect of leaching of CMC, prewetting, and thermogel loading 
method on total colistin loaded within the constructs. Each of these variables had a 
significant effect on loading (p < 0.05), indicated by “*”. Each data point represents the 
mean ± standard deviation for n=8 space maintainers per variable.
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Table 1
Study Design
Group Name CMC Leached Thermogelling
Polymer Present
Prewet Dip (−) vs.
Pregel (+)
No gel
+ − − −
+ − + −
No gel, +CMC
− − − −
− − + −
L:G 1:1
+ + − −
+ + +
+ + + −
+ + +
L:G 3:1
+ + − −
+ + +
+ + + −
+ + +
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Table 2
PMMA Space maintainer Characteristics per Batch
Batch Initial weight (mg) Post-Leach dry weight
(mg)
Post-Leach dry weight
(% initial weight)
1 560 ± 20 440 ± 19 78 ± 3
2 560 ± 15 420 ± 23 75 ± 4
3 570 ± 18 410 ± 13 72 ± 3
4 570 ± 12 430 ± 24 75 ± 4
5 580 ± 11 430 ± 10 74 ± 2
No significant differences amongst any values within each column (p > 0.05).
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Table 3
Space maintainer Weights Before and After Porogen Leaching
Group Prewet Initial weight (mg) Post-Leach dry weight
(% initial weight)
No gel − 570 ± 11 76 ± 4
No gel, +CMC − 580 ± 7 76 ± 2
L:G 1:1, pregel − 560 ± 18 74 ± 2
L:G 1:1, dip − 560 ± 9 73 ± 4
L:G 3:1, pregel − 570 ± 27 75 ± 5
L:G 3:1, dip − 570 ± 19 75 ± 5
No gel + 560 ± 13 75 ± 5
No gel, +CMC + 590 ± 14 75 ± 5
L:G 1:1, pregel + 570 ± 7 74 ± 2
L:G 1:1, dip + 560 ± 8 75 ± 5
L:G 3:1, pregel + 580 ± 13 74 ± 2
L:G 3:1, dip + 560 ± 9 74 ± 2
No significant differences amongst any values within each column (p > 0.05).
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Table 4
Burst Release at 12h as Percentage of Total Release
Group No Prewet (%) Prewet (%)
No gel 73 ± 7 86 ± 2*
No gel, +CMC 84 ± 4 86 ± 1
L:G 1:1, pregel 78 ± 8 87 ± 3*
L:G 1:1, dip 83 ± 2 90 ± 3*
L:G 3:1, pregel 81 ± 6 87 ± 3
L:G 3:1, dip 69 ± 11** 85 ± 5*
*Significantly differs from corresponding “no prewet” value (p < 0.05)
**Significantly differs from all other values except “No gel, no prewet” (p < 0.05)
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Table 5
Bacterial Susceptibility to Released Colistin
Group Prewet MIC for A. baumannii
(μg/ml)
MIC for E. coli (μg/ml)
Colistin standard n/a 8 ± 0 4 ± 0
No gel − 8 ± 0 6 ± 2
No gel, +CMC − 8 ± 0 8 ± 0*
L:G 1:1, pregel − 8 ± 0 8 ± 0*
L:G 1:1, dip − 8 ± 0 8 ± 0*
L:G 3:1, pregel − 8 ± 0 5 ± 2
L:G 3:1, dip − 4 ± 2* 8 ± 0*
No gel + 8 ± 0 8 ± 0*
No gel, +CMC + 8 ± 0 8 ± 0*
L:G 1:1, pregel + 8 ± 0 5 ± 2
L:G 1:1, dip + 8 ± 0 4 ± 0
L:G 3:1, pregel + 8 ± 0 5 ± 2
L:G 3:1, dip + 8 ± 0 5 ± 2
*Significantly differs from corresponding colistin standard (p < 0.05)
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